A new affordable, held-held malaria diagnosis device goes beyond detection—recognizing the DNA markers that suggest which drugs will be the most effective for treatment.
Developed by a team of researchers as part of the European Union-funded Nanomal projects, the NanoMal test can detect the disease within 20 minutes, which is significantly less time than the current minimum of several days. Using nanotechnologies, the unit will analyze the parasite DNA in a blood sample, delivering information about the parasite species and its potential drug resistance in under a half-hour, which allows for the delivery of a personally tailored course of treatment.
In addition to quickly and accurately detecting the presence of malaria, the NanoMal will also allow researchers to gain a better understanding of drug resistance in particular areas.
More Info about this Invention: